TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Lab Pharma AS
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
28,989
|
22,973
|
22,459 |
Financial expenses |
1,372
|
529
|
1,061 |
Earnings before taxes |
2,091
|
-895
|
-1,175 |
Total assets |
8,856
|
5,037
|
4,833 |
Current assets |
6,820
|
2,397
|
2,448 |
Current liabilities |
7,207
|
5,018
|
4,136 |
Equity capital |
1,649
|
19
|
696 |
- share capital |
494
|
529
|
513 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
18.6%
|
0.4%
|
14.4% |
Turnover per employee | |||
Profit as a percentage of turnover |
7.2%
|
-3.9%
|
-5.2% |
Return on assets (ROA) |
39.1%
|
-7.3%
|
-2.4% |
Current ratio |
94.6%
|
47.8%
|
59.2% |
Return on equity (ROE) |
126.8%
|
-4710.5%
|
-168.8% |
Change turnover |
7,539
|
-183
|
-10,927 |
Change turnover % |
35%
|
-1%
|
-33% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.